Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Cases Of Fournier Gangrene Associated With Diabetes Drugs Invokana, Jardiance, And Farxiga

May 9, 2019 By Law Offices of Thomas J. Lamb, P.A.

The FDA has identified 55 unique cases of Fournier gangrene associated with diabetes drugs in the Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors class between March 1, 2013 and January 31, 2019. Of those Fournier gangrene cases, 21 cases were associated with Invokana (canagliflozin), 18 cases were associated with Jardiance (empagliflozin), and 16 cases were associated with Farxiga (dapagliflozin).

This information comes from a new FDA analysis article, “Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases”, published in May 2019 by the medical journal Annals of Internal Medicine.

Lead author Susan Bersoff-Matcha, MD, of the FDA’s Center for Drug Evaluation and Research, and her colleagues emphasized that doctors should carefully watch patients on SGLT2 inhibitors for signs of Fournier gangrene. Further, they made this important point in their article: “Serious complications and death are likely if [Fournier gangrene (FG)] is not recognized immediately and surgical intervention is not carried out within the first few hours of diagnosis.”

In August 2018 the FDA added a warning about the increased risk of developing Fournier gangrene, also known as necrotizing fasciitis of the perineum, to the drug labels for all SGLT2 inhibitors, based on 12 cases reported from March 2013 to May 2018. Now, with this May 2019 medical journal article, there is more evidence that a class of diabetes drugs which includes Invokana, Jardiance, and Farxiga can cause a serious infection in the genital area known as Fournier gangrene.

[View article at original source]

Invokana / Farxiga / Jardiance

Free Case Evaluation

Strictly Confidential, No Obligation

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, diabetes drugs side effects, Farxiga, Fournier’s Gangrene, Invokana, Jardiance, sglt2 inhibitors diabetes drugs

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.